Rosen Law Firm announced a class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) alleging misleading statements about its lead drug, deramiocel. Investors who purchased CAPR securities between October 9, 2024, and July 10, 2025, may be eligible to participate. The deadline to file motions is September 15, 2025.
Pairfection.us, in collaboration with More2Live4, released Success-in-You for Teens, an online program equipping middle and high school students with essential life skills often missing from traditional education. The program addresses gaps in areas like financial literacy and stress management, providing a structured curriculum for personal development.
Air Canada flight attendants overwhelmingly rejected the company's wage offer, citing wages below the federal minimum wage. CUPE President Wesley Lesosky accused Air Canada of bad-faith bargaining, alleging government intervention undermined their negotiating position. Mediation is the next step.
Investors who purchased CTO Realty Growth, Inc. (NYSE: CTO, CTO-PA) securities between February 18, 2021, and June 24, 2025, have until October 7, 2025, to become a lead plaintiff in a securities fraud lawsuit filed by Rosen Law Firm. The lawsuit alleges misrepresentation of financial performance and dividend sustainability.
A 57-year-old investor, Fiftysomething, seeks guidance on managing $70,000 in savings. Currently using Vanguard for IRAs, they are hesitant to use a financial planner for their taxable brokerage account and want to know the best approach to investing this money for retirement. They plan to work until 70.
Picasso Print DTF, a leading provider of Direct-to-Film (DTF) printing services, announced exceeding 60,000 orders. The company invested in technology and infrastructure to meet increased demand, boosting production capacity by 130%. Alp Dalkir highlighted the commitment to speed and quality.
World Lab Technologies (WLT), led by Alexandr Jucov, achieved a significant milestone in its institutional framework. This enhances capital integrity, enforceability, and comparability, setting a new benchmark for global financial markets and benefiting investors, auditors, and regulators.
Meta CEO Mark Zuckerberg's aggressive recruitment of AI talent, including a reported $250 million contract, highlights the current AI spending bubble. Experts question the long-term value of this approach, citing concerns about the limitations of current AI technology and the unrealistic timeline for achieving artificial general intelligence.
BridgeBio Pharma announced positive Phase 2 results for encaleret in post-surgical hypoparathyroidism. Eighty percent of participants achieved normal blood and urine calcium levels within five days, compared to zero percent with conventional treatment. A registration study is planned for 2026.
Chevron is poised for substantial growth, according to Peters. The company anticipates a double-digit increase in free cash flow, potentially boosting returns for shareholders. This positive outlook comes amidst broader market analysis of investment strategies.
The Jim and Mike Savas Team highlights the importance of accurate home pricing in Boston's competitive market. Mispricing, whether over or under, can lead to lost revenue and protracted sales processes. A comparative market analysis (CMA) is crucial for achieving optimal sale prices.
Florida Surgeon General Joseph Ladapo's proposal to eliminate all mandated childhood vaccinations has ignited a firestorm of controversy. His assertion that such mandates constitute "slavery" has drawn sharp criticism from health professionals and some politicians. The plan lacks concrete details and faces significant opposition.
The Trump administration is considering declaring a national housing emergency to address soaring home prices. Treasury Secretary Scott Bessent hinted at potential solutions including zoning law changes and reduced closing costs, but the legality and effectiveness remain uncertain.
Rosen Law Firm filed a securities fraud class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD). Investors who purchased LFMD securities between May 7 and August 5, 2025, may be entitled to compensation. The deadline to become lead plaintiff is October 27, 2025.
The aging U.S. population, particularly those over 85, presents a significant challenge. Harry Margolis highlights the inadequacy of the current elder care system and the urgent need for innovative solutions to address the rapidly growing demand.
Faruqi & Faruqi, LLP is investigating potential claims against Replimune (NASDAQ: REPL) following a significant stock drop. Investors who suffered losses between November 22, 2024, and July 21, 2025, are urged to contact the firm before the September 22, 2025 deadline.
Pomerantz LLP is investigating Fly-E Group, Inc. (NASDAQ: FLYE) following a critical report alleging stock manipulation and safety concerns. The Bear Cave report triggered a sharp decline in Fly-E's stock price, prompting the law firm's inquiry into potential securities fraud. Investors are encouraged to contact Pomerantz LLP.